CMS issued the Calendar Year 2023 Physician Fee Schedule proposed rule, which would significantly expand access to behavioral health services, Accountable Care Organizations, cancer screening, and dental care – particularly in rural and underserved areas.
The Biden Administration, through the U.S. Department of Health and Human Services and the Centers for Medicare & Medicaid Services, announced a new model aimed at improving cancer care for Medicare patients and lowering health care costs.
Intervention Insights is pleased to announce the availability of Trapelo a true advancement in the use of molecular science and targeted therapies for cancer patients.
The U.S. Food and Drug Administration approved the FoundationOne CDx, the first breakthrough-designated, next generation sequencing (NGS)-based in vitro diagnostic test that can detect genetic mutations in 324 genes and two genomic signatures in any solid tumor type.
Astellas announced the five C3 Prize finalists chosen to present their ideas live at the Stanford Medicine X conference on Sept. 17 to a panel of judges including Robert Herjavec, dynamic entrepreneur, passionate cancer caregiver and star of ABC’s Emmy Award-winning television show, Shark Tank.